Becton, Dickinson and (BDX) Fair Value & DCF

BDX$209.19—
Medical - Instruments & SuppliesLarge Cap
Compare
Market cap$57.96BEnterprise value—Revenue (TTM)$20.22BMarket positionTop 25%

Score

44
Bearish
Value
43
Quality
49
Growth
39

Becton, Dickinson and Company (BDX) trades at $209.19 on $57.96B of equity value, with a trailing P/E of 50.64. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Becton, Dickinson and (BDX) Fair Value & DCF

BDX price $209.19 —

Ticker
BDX
Price
$209.19
Change
—
Market cap
$57.96B
P/E
50.64
Forward P/E
16.08
Dividend yield
1.88%
Beta
0.28
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Stocklytics score
44
Value
43
Quality
49
Growth
39

Stocklytics score rationale: value 43, quality 49, growth 39.

AI Score 65. Becton, Dickinson and Company (BDX) has a market cap of approximately $57.7 billion and a high price-to-earnings ratio of about 51.1, indicating potential overvaluation. Despite solid gross profit margins of 47% and a strong current ratio of 8.81, the company has faced challenges with net income margins around 5.7%, suggesting pressure on profitability

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener